 |
Sodium Monomercaptoundecahydro-closo-dodecaborate |
|---|---|
| Trade Name | Borocell |
| Orphan Indication | Glioblastoma |
| USA Market Approval | USA |
| USA Designation Date | 1992-04-15 00:00:00 |
| Sponsor | Neutron Technology Corp.& Neutron R&D; Partner;877 Main Street, Suite 402;Boise, Idaho, 83702 |
